SEC 13F Intelligence

Venrock Adviser, LLC / VRDN

Venrock Adviser, LLC’s Viridian Therapeutics Inc Position

Does Venrock Adviser, LLC own Viridian Therapeutics Inc (VRDN)? Yes — 3.88M shares worth $76M (+2.83% of its 13F portfolio) as of Q1 2026.

Position Value
$76M
Q1 2026
Shares
3.88M
% of Portfolio
+2.83%
Quarters Held
22
currently held

Position History VRDN

Reported value by quarter
Q4 ’20: $321,000Q4 ’20Q1 ’21: $326,000Q2 ’21: $357,000Q3 ’21: $321,000Q3 ’21Q4 ’21: $37MQ1 ’22: $34MQ2 ’22: $21MQ2 ’22Q3 ’22: $44MQ4 ’22: $79MQ1 ’23: $69MQ1 ’23Q2 ’23: $73MQ3 ’23: $47MQ4 ’23: $85MQ4 ’23Q1 ’24: $68MQ2 ’24: $51MQ3 ’24: $88MQ3 ’24Q4 ’24: $74MQ1 ’25: $52MQ2 ’25: $54MQ2 ’25Q3 ’25: $84MQ4 ’25: $121MQ1 ’26: $76MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20263.88M$76M+2.83%
Q4 20253.88M$121M+5.97%
Q3 20253.88M$84M+4.72%
Q2 20253.88M$54M+4.07%
Q1 20253.88M$52M+4.45%
Q4 20243.88M$74M+5.11%
Q3 20243.88M$88M+4.63%
Q2 20243.88M$51M+3.22%
Q1 20243.88M$68M+3.23%
Q4 20233.88M$85M+5.80%
Q3 20233.08M$47M+4.98%
Q2 20233.08M$73M+11.73%
Q1 20232.70M$69M+13.41%
Q4 20222.70M$79M+12.66%
Q3 20222.13M$44M+6.42%
Q2 20221.85M$21M+3.87%
Q1 20221.85M$34M+5.55%
Q4 20211.85M$37M+5.01%
Q3 202119.5K$321,000+0.04%
Q2 202119.5K$357,000+0.04%
Q1 202119.5K$326,000+0.04%
Q4 202019.5K$321,000+0.05%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Venrock Adviser, LLC’s full portfolio or all institutional holders of VRDN.